(R)-tert-Butyl 3-(4-Aminophenyl)piperidine-1-carboxylate
- CAS
- 1263284-59-8
- Formula
- C16H24N2O2
- MW
- 276.37 g/mol
VQ-026924
Impurity reference standards
Niraparib impurities & reference standards
Characterised Niraparib impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
21reference materials
COAHPLC · NMR · MS on request
(S)-2-(4-(1-(tert-Butoxycarbonyl)piperidin-3-yl)phenyl)-2H-indazole-7-carboxylic Acid
- CAS
- 1038916-08-3
- Formula
- C24H27N3O4
- MW
- 421.5 g/mol
VQ-038656
(S)-tert-Butyl 3-(4-Aminophenyl)piperidine-1-carboxylate
- CAS
- 1171197-20-8
- Formula
- C16H24N2O2
- MW
- 276.37 g/mol
VQ-035363
Methyl (E)-3-(2-(dimethylamino)vinyl)-2-nitrobenzoate
- CAS
- 68109-89-7
- Formula
- C12H14N2O4
- MW
- 250.25 g/mol
VQ-032174
Methyl 3-(2-(dimethylamino)vinyl)-2-nitrobenzoate
- CAS
- 93247-79-1
- Formula
- C12H14N2O4
- MW
- 250.25 g/mol
VQ-026925
tert-Butyl (4-(piperidin-3-yl)phenyl)carbamate
- CAS
- 887589-62-0
- Formula
- C16H24N2O2
- MW
- 276.37 g/mol
VQ-038659
tert-Butyl (S)-3-(4-(7-carbamoyl-2H-indazol-2-yl)phenyl)piperidine-1-carboxylate
- CAS
- 1038916-11-8
- Formula
- C24H28N4O3
- MW
- 420.5 g/mol
VQ-023268
tert-Butyl (S)-3-(4-(7-cyano-2H-indazol-2-yl)phenyl)piperidine-1-carboxylate
- CAS
- 1476776-81-4
- Formula
- C24H26N4O2
- MW
- 402.49 g/mol
VQ-038657
Tert-butyl 3-(4-aminophenyl)-5,6-dihydropyridine-1(2H)-carboxylate
- Formula
- C16H22N2O2
- MW
- 274.36 g/mol
In stock
tert-Butyl 4-(4-aminophenyl)piperidine-1-carboxylate
- CAS
- 170011-57-1
- Formula
- C16H24N2O2
- MW
- 276.37 g/mol
VQ-044817
FAQs — Niraparib impurities
Which Niraparib impurities do you supply?
We list 21 Niraparib-related reference materials, including process impurities, degradation products and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Niraparib impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Niraparib impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Niraparib impurity standards
We reply within one business day with price, pack options, lead time and documentation.